Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Therapeutic Innovation & Regulatory Science|April 7, 2026
The Future of Biologics: Lessons from Hatch-WaxmanBrian J Miller, Janet WoodcockHealth Affairs (Project Hope)|November 11, 2008
The human genome and translational research: how much evidence is enough?Janet WoodcockBiomarkers in Medicine|May 19, 2010
Interview with Janet Woodcock: progress on the FDA's critical path initiativeJanet WoodcockNature Reviews. Drug Discovery|November 1, 2014
Paving the critical path of drug development: the CDER perspectiveJanet WoodcockDrug Discovery Today|June 19, 2004
Janet Woodcock discusses the FDA and the drug development process. Interview by Christopher WatsonJanet WoodcockAnnual Review of Medicine|January 12, 2008
The FDA critical path initiative and its influence on new drug developmentJanet Woodcock, Raymond WoosleyInternational Journal of Pharmaceutics|June 2, 2015
FDA pharmaceutical quality oversightLawrence X Yu, Janet WoodcockValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Value Assessment in the Regulatory ContextKathleen L Miller, Janet WoodcockHealth Affairs (Project Hope)|November 3, 2010
Comparative effectiveness research: who will do the studies?Robert B Giffin, Janet WoodcockPageof 18